Cancer Screening Capsule Cleared for Marketing in Israel

Israel’s Ministry of Health granted Check-Cap marketing approval for its C-Scan capsule for colorectal cancer (CRC) screening.

The ingestible capsule, which received the CE Mark in January, gives physicians structural information about the endoluminal surface of the patient’s colon.

The product can be used for screening CRC in patients at average risk for the disease who cannot or do not wish to receive a colonoscopy.